1家供應(yīng)商在售
|
||||||
商品名稱(chēng) | 規(guī)格 | 代理級(jí)別 | 價(jià)格 | 運(yùn)費(fèi) | 供應(yīng)商 | 購(gòu)買(mǎi) |
Ly6k (E4K8Y) XP ? Rabbit mAb
交貨周期:現(xiàn)貨
|
20 μl | 經(jīng)銷(xiāo) |
登錄可見(jiàn)
|
- |
北京敏泰元科技有限公司 |
庫(kù)存:20
|
REACTIVITY | M |
SENSITIVITY | Endogenous |
MW (kDa) | 18 |
Source/Isotype | Rabbit IgG |
Application | Dilution |
---|---|
Western Blotting | 1:1000 |
Immunoprecipitation | 1:200 |
IHC-Leica? Bond? | 1:200 - 1:800 |
Immunohistochemistry (Paraffin) | 1:200 - 1:800 |
Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 μg/ml BSA, 50% glycerol and less than 0.02% sodium azide. Store at –20°C. Do not aliquot the antibody.
Ly6k (E4K8Y) XP? Rabbit mAb recognizes endogenous levels of total Ly6k protein.
Mouse
Monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Pro70 of murine Ly6k protein.
Cancer/testis antigens (CTAs) are a family of more than 100 proteins whose normal expression is largely restricted to immune privileged germ cells of the testis, ovary, and trophoblast cells of the placenta. Although most normal somatic tissues are void of CTA expression, due to epigenetic silencing of gene expression, their expression is upregulated in a wide variety of human solid and liquid tumors (1,2). As such, CTAs have garnered much attention as attractive targets for a variety of immunotherapy-based approaches to selectively attack tumors (3).
Ly6k is a member of the Ly6/urokinase type plasminogen activator receptor-like protein (uPAR)(LU) superfamily. It is expressed in testes where in interaction with another (uPAR)(LU) family member, TEX101, it is proposed to be necessary for the production of viable sperm (4). The human ortholog of this protein, LY6K, has been characterized to be a CTA. It is found to be upregulated in numerous types of cancer, including esophageal squamous cell carcinoma, bladder cancer, and breast cancer (5,6).
商城介紹 | 媒體報(bào)道 | 法規(guī)政策 | 協(xié)議專(zhuān)區(qū)
京公網(wǎng)安備 11010802025067號(hào) 增值電信業(yè)務(wù)經(jīng)營(yíng)許可證:京B2-20171454 ICP備案號(hào):京ICP備16050672號(hào)-1
喀斯瑪科技版權(quán)所有 2017-
藥品醫(yī)療器械網(wǎng)絡(luò)信息服務(wù)備案: (京)-網(wǎng)藥械信息備字(2022)第00393號(hào)
醫(yī)療器械網(wǎng)絡(luò)交易服務(wù)第三方平臺(tái)備案編號(hào):京網(wǎng)械平臺(tái)備字(2021)第00006號(hào)
網(wǎng)絡(luò)食品交易第三方平臺(tái)提供者備案 :京食藥網(wǎng)食備202110062 信息系統(tǒng)安全等級(jí)保護(hù)備案證明(三級(jí))